Maternal cigarette smoking, metabolic gene polymorphisms, and preterm delivery: new insights on GxE interactions and

Hui-Ju Tsai1, Xin Liu, Karen Mestan

  • 1Mary Ann and J. Milburn Smith Child Health Research Program, Children's Memorial Hospital and Children's Memorial Research Center, Department of Pediatrics, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. htsai@childrensmemorial.org

Human Genetics
|March 6, 2008
PubMed

Insights

Maternal smoking combined with specific genetic variations in CYP1A1 and GSTT1 significantly elevates the risk of preterm delivery (PTD). This combined effect is particularly pronounced in spontaneous PTD and cases with histologic chorioamnionitis.

Area of Science:

  • Genetics and Epigenetics
  • Reproductive Health
  • Public Health

Background:

  • Preterm delivery (PTD) is a major global health concern.
  • Maternal smoking and specific gene polymorphisms are known risk factors for adverse pregnancy outcomes.
  • Previous research indicated a synergistic effect of smoking and gene variants on low birth weight.

Purpose of the Study:

  • To investigate the combined effects of maternal smoking and CYP1A1 MspI/GSTT1 gene polymorphisms on preterm delivery.
  • To analyze these associations in the overall PTD population and specific preterm subgroups.
  • To explore potential ethnic variations in these relationships.

Main Methods:

  • A case-control study involving 1,749 multi-ethnic mothers.
  • Regression analyses were used to assess individual and joint associations.
  • Covariates were adjusted for in the statistical models.

Main Results:

  • Maternal smoking showed a moderate association with PTD (OR = 1.6).
  • A significant joint association was found between maternal smoking and high-risk CYP1A1/GSTT1 genotypes with PTD (OR = 5.8).
  • This joint effect was strongest in spontaneous PTD, PTD < 32 weeks, and PTD with histologic chorioamnionitis.

Conclusions:

  • Maternal smoking significantly increases PTD risk in women with high-risk CYP1A1 and GSTT1 genotypes.
  • The synergistic effect of smoking and these genotypes is most pronounced in PTD cases with histologic chorioamnionitis.
  • These findings highlight the importance of genetic susceptibility in mediating the impact of smoking on preterm birth.

Related Concept Videos

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Pharmacogenetics of Drug Metabolism: Overview01:27

Pharmacogenetics of Drug Metabolism: Overview

Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Animal Mitochondrial Genetics02:59

Animal Mitochondrial Genetics

Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...